137 related articles for article (PubMed ID: 15828177)
21. Cytotoxicity of arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine to Epstein-Barr virus producer and nonproducer lymphoma cells in culture.
Margalith M; Manor D; Cohen T
Cancer Biochem Biophys; 1983; 6(3):189-96. PubMed ID: 6303555
[TBL] [Abstract][Full Text] [Related]
22. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs.
Richards JT; Kern ER; Overall JC; Glasgow LA
Antiviral Res; 1982 May; 2(1-2):27-39. PubMed ID: 6179469
[TBL] [Abstract][Full Text] [Related]
23. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
Lerner AM; Bailey EJ
J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
[TBL] [Abstract][Full Text] [Related]
24. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
Shipman C; Smith SH; Carlson RH; Drach JC
Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside.
Babiuk LA; Meldrum B; Gupta VS; Rouse BT
Antimicrob Agents Chemother; 1975 Dec; 8(6):643-50. PubMed ID: 1239978
[TBL] [Abstract][Full Text] [Related]
26. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
Plunkett W; Cohen SS
Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
[TBL] [Abstract][Full Text] [Related]
27. Effects of a new adenosine deaminase inhibitor, isocoformycin, on toxicity, antitumor activity and tissue distribution of formycin A and 9-beta-D-arabinofuranosyladenine.
Hidaka T; Katayama K; Yamashita K; Yamashita T; Watanabe K; Shimazaki M; Ohno M; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Mar; 33(3):303-9. PubMed ID: 7380742
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative effects of 9-beta-d-arabinofuranosyladenine in a mammalian cell line devoid of adenosine deaminase activity.
Drach JC; Sandberg JN; Shipman C
J Dent Res; 1977 Mar; 56(3):275-88. PubMed ID: 192768
[TBL] [Abstract][Full Text] [Related]
29. Antiviral activity of adenine arabinoside and iododeoxyuridine in human fetal intestinal and tracheal organ cultures.
Dolin R; Smith HA
J Infect Dis; 1975 Sep; 132(3):287-95. PubMed ID: 169312
[TBL] [Abstract][Full Text] [Related]
30. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
White EL; Shaddix SC; Brockman RW; Bennett LL
Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
[TBL] [Abstract][Full Text] [Related]
32. 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.
Averett DR; Koszalka GW; Fyfe JA; Roberts GB; Purifoy DJ; Krenitsky TA
Antimicrob Agents Chemother; 1991 May; 35(5):851-7. PubMed ID: 1649571
[TBL] [Abstract][Full Text] [Related]
33. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.
Plunkett W; Cohen SS
Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161
[No Abstract] [Full Text] [Related]
34. Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine.
Helland S; Ueland PM
Cancer Res; 1982 Jul; 42(7):2861-6. PubMed ID: 6979384
[TBL] [Abstract][Full Text] [Related]
35. [Comparative study of antiherpetic effect of 9-beta-D-xylofuranosyl- adenine and 9-beta-D-arabinofuranosyladenine and their inhibition of defective herpes simplex type 1 virus in a cell culture].
Shobukhov VM; Kiseleva NV; Pravdina NF; Kaz'mina EM; Galegov GA
Vopr Virusol; 1989; 34(6):741-4. PubMed ID: 2561237
[No Abstract] [Full Text] [Related]
36. Variables influencing the in vitro susceptibilities of herpes simplex viruses to antiviral drugs.
Marks MI
Antimicrob Agents Chemother; 1974 Jul; 6(1):34-8. PubMed ID: 15828168
[TBL] [Abstract][Full Text] [Related]
37. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture.
Cass CE; Tan TH; Selner M
Cancer Res; 1979 May; 39(5):1563-9. PubMed ID: 85484
[TBL] [Abstract][Full Text] [Related]
38. 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus.
Koszalka GW; Averett DR; Fyfe JA; Roberts GB; Spector T; Biron K; Krenitsky TA
Antimicrob Agents Chemother; 1991 Jul; 35(7):1437-43. PubMed ID: 1656862
[TBL] [Abstract][Full Text] [Related]
39. Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside.
Harmenberg JG; Svensson LT
Acta Virol; 1988 Mar; 32(2):153-5. PubMed ID: 2899962
[TBL] [Abstract][Full Text] [Related]
40. Study on the apparent resistant strains of herpes simplex virus type 1 against 9-beta-D-arabinofuranosyladenine.
Yoshida T; Suzutani T; Azuma M
Tohoku J Exp Med; 1988 Nov; 156(3):279-90. PubMed ID: 2855280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
